HTATSF1 and neoplasm: Next, shRNA-resistant HTATSF1/Wt, HTATSF1/S748A, and HTATSF1/S748D were individually stably transfected into HTATSF1-depleted MDA-MB-231 cells, and the tumor formation of these cancer cells was assessed using a cisplatin-challenged xenograft model.